• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,237.99 -160.73
( -0.21%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
17.34
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
329.33
75.34
EPS(TTM)
Face Value()
Div & Yield %
0.15
10
0
 

Aditya Birla Capital consolidated net profit rises 30.60% in the March 2026 quarter
May 04,2026
Net profit of Aditya Birla Capital rose 30.60% to Rs 1129.16 crore in the quarter ended March 2026 as against Rs 864.60 crore during the previous quarter ended March 2025. Sales rose 10.19% to Rs 13459.25 crore in the quarter ended March 2026 as against Rs 12214.04 crore during the previous quarter ended March 2025.

For the full year,net profit rose 12.97% to Rs 3764.49 crore in the year ended March 2026 as against Rs 3332.32 crore during the previous year ended March 2025. Sales rose 12.12% to Rs 45508.98 crore in the year ended March 2026 as against Rs 40589.98 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales13459.2512214.04 10 45508.9840589.98 12
OPM %33.6931.07 -36.6835.06 -
PBDT1627.721428.94 14 5631.815089.04 11
PBT1545.841360.83 14 5325.184842.84 10
NP1129.16864.60 31 3764.493332.32 13